Literature DB >> 33964632

Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.

Xin Shelley Wang1, Qiuling Shi2, Loretta A Williams2, Heather A Lillemoe3, Ting-Yu Chen2, Vijaya Gottumukkala4, Araceli Garcia-Gonzalez2, Donna Malveaux2, Mona Kamal5, Charles S Cleeland2, Thomas A Aloia6.   

Abstract

PURPOSE: Based on the MD Anderson Symptom Inventory (MDASI), we developed a Patient-reported outcomes tool for hepatectomy perioperative care (MDASI-PeriOp-Hep).
METHODS: To establish the content validity, we generated PeriOp-Hep-specific candidate items from qualitative interviews of patients (n = 30), and removed items that lacked clinical relevance on the basis of input from panels of patients, caregivers, and clinicians. The psychometric properties of the MDASI-PeriOp-Hep were validated (n = 150). The cognitive debriefing and clinical interpretability were assessed to confirm the ease of comprehension, relevance, and acceptability of the tool.
RESULTS: Five symptoms specific to hepatectomy (abdominal bloating, tightness, or fullness; abdominal cramping; muscle weakness, instability, or vertigo; constipation; and incisional tightness) were identified as module items to form the MDASI-PeriOp-Hep. The Cronbach αs for symptoms and for interference were 0.898 and 0.861, respectively. The test-retest reliability was 0.887 for all 18 symptom severity items. Compared to other commonly used tools, correlation of MDASI-PeriOp-Hep scores to performance status (all, P < 0.001) and to the phase of perioperative care confirmed known-group validity. Convergent validity was excellent against other standard Patient-reported outcomes tools. Cognitive debriefing demonstrated that the MDASI-PeriOp-Hep was an easy to use and understandable tool.
CONCLUSIONS: For integrating patient-reported outcomes in perioperative patient care, a procedure-specific tool is desirable. The MDASI-PeriOp-Hep is a valid, reliable, concise tool for measuring symptom severity and functional interference in patients undergoing liver surgery.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Functional recovery; Liver surgery; MDASI; Patient-reported outcome; Perioperative care; Symptom burden; Validation

Mesh:

Year:  2021        PMID: 33964632      PMCID: PMC8650165          DOI: 10.1016/j.ejon.2021.101959

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.588


  19 in total

1.  Advancing our knowledge of symptom clusters.

Authors:  Marylin J Dodd; Maria H Cho; Bruce Cooper; Christine Miaskowski; Kathryn A Lee; Kayee Bank
Journal:  J Support Oncol       Date:  2005 Nov-Dec

2.  Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

Authors:  Charles S Cleeland; Xin Shelley Wang; Qiuling Shi; Tito R Mendoza; Sherry L Wright; Madonna D Berry; Donna Malveaux; Pankil K Shah; Ibrahima Gning; Wayne L Hofstetter; Joe B Putnam; Ara A Vaporciyan
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

3.  How well are we measuring postoperative "recovery" after abdominal surgery?

Authors:  Lawrence Lee; Teodora Dumitra; Julio F Fiore; Nancy E Mayo; Liane S Feldman
Journal:  Qual Life Res       Date:  2015-05-24       Impact factor: 4.147

4.  Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.

Authors:  Kiyohiko Omichi; Junichi Shindoh; Jordan M Cloyd; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Ching-Wei D Tzeng; Jean-Nicolas Vauthey
Journal:  Eur J Surg Oncol       Date:  2017-11-24       Impact factor: 4.424

5.  Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms.

Authors:  Xin Shelley Wang; Diane L Fairclough; Zhongxing Liao; Ritsuko Komaki; Joe Y Chang; Gary M Mobley; Charles S Cleeland
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

6.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

7.  Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer.

Authors:  Qiuling Shi; Xin Shelley Wang; Ara A Vaporciyan; David C Rice; Keyuri U Popat; Charles S Cleeland
Journal:  J Pain Symptom Manage       Date:  2016-08-10       Impact factor: 3.612

8.  Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.

Authors:  J M Blazeby; P Fayers; T Conroy; O Sezer; J Ramage; M Rees
Journal:  Br J Surg       Date:  2009-03       Impact factor: 6.939

9.  International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.

Authors:  Wei-Chu Chie; Jane M Blazeby; Chin-Fu Hsiao; Herng-Chia Chiu; Ronnie T Poon; Naoko Mikoshiba; Gillian Al-Kadhimi; Nigel Heaton; Jozer Calara; Peter Collins; Katharine Caddick; Anna Costantini; Valerie Vilgrain; Ludovic Trinquart; Chieh Chiang
Journal:  Hepatology       Date:  2012-03-01       Impact factor: 17.425

Review 10.  User's guide to correlation coefficients.

Authors:  Haldun Akoglu
Journal:  Turk J Emerg Med       Date:  2018-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.